86

Comey: Well, they're back. This time about a picture of seashells on a North Carolina beach a year ago. And this won't be the end of it.But nothing has changed with me. I'm still innocent. I'm still not afraid. And I still believe in the independent federal judiciary. So let's go.

— MeidasTouch (@meidastouch.com) 2026-04-28T21:50:20.278Z

Unambiguously a violation of grand jury secrecy in a way that would normally be a massive problem, and in this instance is about a dozen items down the list.

— Andy Craig (@andycraig.bsky.social) 2026-04-28T22:29:10.414Z

Sure, let Joe decide

Fda Launches Real-Time Access Plan For Clinical Trial Data With AstraZeneca And Amgen — The FDA announced a new initiative that would let its reviewers access clinical trial information in real time, aiming to speed and strengthen oversight. AstraZeneca and Amgen are already…

— BizToc (@biztoc.com) 2026-04-28T23:01:03.419Z

"This is setting off alarm bells because it suggests the president is doing an end-run around the FDA’s normal scientific processes, quite possibly because he wants to quiet a politically influential podcaster who has been giving him grief over Iran."

— The Bulwark (@thebulwark.com) 2026-04-28T23:00:59.278Z

I don’t get it

I don’t understand why so many people are pushing for this guy, especially for the Senate.

Good for him but I am tired of learning about all the ways a 41-year-old candidate for U.S. Senate supposedly has a lot more growing and learning to do. Maybe do that before the Senate? And maybe try out a lower office before then?Or maybe we just watch him blossom into another Sinema/Fetterman.

— Max Kennerly (@maxkennerly.bsky.social) 2026-04-16T02:15:45.297Z